Bola S. Hanna
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients.
Journal: Leukemia
Published: January 28, 2021
Interleukin-10 receptor signaling promotes the maintenance of a PD-1int TCF-1+ CD8+ T cell population that sustains anti-tumor immunity.
Journal: Immunity
Published: January 09, 2021
EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia.
Journal: Leukemia
Published: July 01, 2020
Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice.
Journal: Haematologica
Published: March 07, 2020
CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion.
Journal: Leukemia & lymphoma
Published: September 15, 2019
TBET-expressing Th1 CD4+ T cells accumulate in chronic lymphocytic leukaemia without affecting disease progression in Eµ-TCL1 mice.
Journal: British journal of haematology
Published: May 17, 2019
Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues.
Journal: Leukemia
Published: June 14, 2018
Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia.
Journal: International journal of cancer
Published: May 09, 2018
Beyond bystanders: Myeloid cells in chronic lymphocytic leukemia.
Journal: Molecular immunology
Published: August 11, 2017
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin.
Journal: Haematologica
Published: July 31, 2017
Last Updated: 09/26/2026